- Joined
- May 22, 2009
- Posts
- 12,965
- Qantas
- Platinum 1
- Oneworld
- Emerald
- Star Alliance
- Gold
ATAGI hasn’t released their most up to date advice on this yet.The official UK advice is that you should defer your second dose until more is known.
Some more reading.
COVID-19 vaccine-induced myocarditis: Case report with literature review - PMC
www.ncbi.nlm.nih.gov
Myocarditis and pericarditis after immunization: Gaining insights through the Vaccine Adverse Event Reporting System - PubMed
Myocarditis and pericarditis after immunization: Gaining insights through the Vaccine Adverse Event Reporting Systempubmed.ncbi.nlm.nih.gov
Clinical Considerations: Myocarditis after COVID-19 Vaccines | CDC
Clinical considerations for myocarditis and pericarditis after receipt of mRNA COVID-19 Vaccines among adolescents and young adults.www.cdc.gov
Myocarditis With COVID-19 mRNA Vaccines
Myocarditis has been recognized as a rare complication of coronavirus disease 2019 (COVID-19) mRNA vaccinations, especially in young adult and adolescent males. According to the US Centers for Diseaswww.ahajournals.org
I will try and remember to ask about the ATAGI advice tomorrow.
There is a general recommendation that if someone has suffered a serious adverse event (myocarditis etc) then the second dose could be AZ at 4-12 weeks following risk assessment.
ATAGI Second Dose Special Circumstances